Molecular epidemiologic features of inflammatory breast cancer: A comparison between Egyptian and US patients

Breast Cancer Research and Treatment

Volumn 112, Issue 1, 2008, Pages 141-147

  Lo, An Chi ^a   Kleer, Celina G ^b   Banerjee, Mousumi ^a   Omar, Sherif ^c   Khaled, Hussein ^c   Eissa, Saad ^c   Hablas, Ahmed ^d   Douglas, Julie A ^b   Alford, Sharon H ^e   Merajver, Sofia D ^b   Soliman, Amr S ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c CAIRO UNIVERSITY   (Egypt)

^d Gharbia Cancer Society   (Egypt)

^e HENRY FORD HOSPITAL   (United States)

Author keywords

Inflammatory breast cancer; International; LYVE 1; Molecular epidemiology; RhoC; Tumor emboli

Indexed keywords

CELL RECEPTOR; LYMPHATIC VESSEL ENDOTHELIAL RECEPTOR 1; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOC GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; EGYPT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BREAST CANCER; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR EMBOLISM; UNITED STATES;

ADULT; AGED; BREAST NEOPLASMS; EGYPT; EPIDEMIOLOGIC STUDIES; EPIDEMIOLOGY, MOLECULAR; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; INFLAMMATION; MEDICAL RECORDS; MIDDLE AGED; PROGNOSIS; RHO GTP-BINDING PROTEINS; TISSUE ARRAY ANALYSIS; UNITED STATES; VESICULAR TRANSPORT PROTEINS;

EID: 52949143119     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9833-z     Document Type: Article

References (37)

1. HL Brooks N Mandava WF Pizzi S Shah 1998 Inflammatory breast carcinoma: a community hospital experience J Am Coll Surg 186 622 629
2. PA Wingo PM Jamison JL Young P Gargiullo 2004 Population-based statistics for women diagnosed with inflammatory breast cancer (United States) Cancer Causes Control 15 321 328
3. KW Hance WF Anderson SS Devesa HA Young PH Levine 2005 Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute J Natl Cancer Inst 97 966 975
4. S Chang SL Parker T Pham AU Buzdar SD Hursting 1998 Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992 Cancer 82 2366 2372
5. Anderson WF, Schairer C, Chen BE, Hance KW, Levine PH (2005-2006) Epidemiology of inflammatory breast cancer (IBC). Breast Dis 22:9-23
6. Merajver SD, Goodman VL, Sabel MS (2006) Inflammatory breast cancer: advances in molecular genetics and treatment. In: Bonadonna G, Hortobagyi GN, Valagussa P (eds) Textbook of breast cancer: a clinical guide to therapy, 3rd edn. Taylor and Francis, London, pp 241-256
7. El Halim GEM (1988) Clinical, immunological and hormonal profile of inflammatory carcinoma of the breast. Ph.D. Dissertation, Cairo University, Egypt
8. S Omar H Khaled 2002 Inflammatory breast cancer Newsl Int Netw Cancer Treat Res 3 1 3
9. CG Kleer KL van Golen SD Merajver 2000 Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants Breast Cancer Res 2 423 429
10. P Bonnier C Charpin C Lejeune S Romain N Tubiana B Beedassy PM Martin H Serment L Piana 1995 Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition? Int J Cancer 62 382 385
11. G Gruber M Ciriolo HJ Altermatt S Aebi G Berclaz RH Greiner 2004 Prognosis of dermal lymphatic invasion with or without clinical signs of inflammatory breast cancer Int J Cancer 109 144 148
12. MG Le R Arriagada G Contesso M Cammoun F Pfeiffer F Tabbane J Bahi M Dilaj M Spielmann JP Travagli T Tursz N Mourali 2005 Dermal lymphatic emboli in inflammatory and noninflammatory breast cancer: a French-Tunisian joint study in 337 patients Clin Breast Cancer 6 439 445
13. KL van Golen S Davies ZF Wu Y Wang CD Bucana H Root S Chandrasekharappa M Strawderman SP Ethier SD Merajver 1999 A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype Clin Cancer Res 5 2511 2519
14. S Banerji J Ni SX Wang S Clasper J Su R Tammi M Jones DG Jackson 1999 LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan J Cell Biol 144 789 801
15. MA Al-Rawi RE Mansel WG Jiang 2005 Molecular and cellular mechanisms of lymphangiogenesis Eur J Surg Oncol 31 117 121
16. CG Kleer KL van Golen Y Zhang ZF Wu MA Rubin SD Merajver 2002 Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability Am J Pathol 160 579 584
17. CG Kleer KA Griffith MS Sabel G Gallagher KL van Golen ZF Wu SD Merajver 2005 RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast Breast Cancer Res Treat 93 101 110
18. LD Lehmkuhl 1996 Nonparametric statistics: methods for analyzing data not meeting assumptions required for the application of parametric tests J Prosthet Orthot 18 105 113
19. Hatcher L (2003) Step-by-step basic statistics using SAS: student guide. SAS Institute Inc., Cary
20. B Hoogstraten N Gad-El-Mawla MR Hamsa I Abdelaziz Y Omar 1982 Breast cancer in Arabic women Oncology 39 134 139
21. F Tabbane J Bahi K Rahal A el May M Riahi M Cammoun M Hechiche M Jaziri N Mourali 1989 Inflammatory symptoms in breast cancer. Correlations with growth rate, clinicopathologic variables, and evolution Cancer 64 2081 2089
22. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M (eds) (2002) AJCC cancer staging manual, 6th edn. Springer, New York, pp 225-226
23. IA Jaiyesimi AU Buzdar G Hortobagyi 1992 Inflammatory breast cancer: a review J Clin Oncol 10 1014 1024
24. I van der Auwera SJ van Laere GG van den Eynden I Benoy P van Dam CG Colpaert SB Fox H Turley AL Harris EA Van Marck PB Vermeulen LY Dirix 2004 Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification Clin Cancer Res 10 7965 7971
25. I van der Auwera GG van den Eynden CG Colpaert SJ van Laere P van Dam EA van Marck LY Dirix PB Vermeulen 2005 Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study Clin Cancer Res 11 7637 7642
26. T Makinen C Norrmen TV Petrova 2007 Molecular mechanisms of lymphatic vascular development Cell Mol Life Sci 64 1915 1929
27. KL van Golen ZF Wu XT Qiao L Bao SD Merajver 2000 RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells Neoplasia 2 418 425
28. KL van Golen ZF Wu XT Qiao LW Bao SD Merajver 2000 RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype Cancer Res 60 5832 5838
29. GG van den Eynden I van der Auwera S van Laere CG Colpaert P van Dam S Merajver CG Kleer AL Harris EA van Marck LY Dirix PB Vermeulen 2004 Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer Breast Cancer Res Treat 85 13 22
30. Q Pan LW Bao CG Kleer MS Sabel KA Griffith TN Teknos SD Merajver 2005 Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy Cancer Res 65 8366 8371
31. Q Pan LW Bao TN Teknos SD Merajver 2006 Targeted disruption of protein kinase C{varepsilon} reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma Cancer Res 66 9379 9384
32. CG Kleer TN Teknos M Islam B Marcus JS Lee Q Pan SD Merajver 2006 RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck Clin Cancer Res 12 4485 4490
33. M Wu ZF Wu C Kumar-Sinha A Chinnaiyan SD Merajver 2004 RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells Breast Cancer Res Treat 84 3 12
34. AS Soliman X Wang J DiGiovanni S Eissa M Morad S Vulimiri KG Mahgoub DA Johnston KA Do IA Seifeldin P Boffetta ML Bondy 2003 Serum organochlorine levels and history of lactation in Egypt Environ Res 92 110 117
35. AS Soliman SV Vulimiri HE Kleiner J Shen S Eissa M Morad H Taha F Lukmanji D Li DA Johnston HH Lo S Lau J Digiovanni ML Bondy 2004 High levels of oxidative DNA damage in lymphocyte DNA of premenopausal breast cancer patients from Egypt Int J Environ Health Res 14 121 134
36. S Chang AU Buzdar SD Hursting 1998 Inflammatory breast cancer and body mass index J Clin Oncol 16 3731 3735
37. S Chang JR Alderfer L Asmar AU Buzdar 2000 Inflammatory breast cancer survival: the role of obesity and menopausal status at diagnosis Breast Cancer Res Treat 64 157 163